We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Matrixx Opens Door For Plaintiffs, But Only A Crack

Law360 (March 22, 2011, 7:09 PM EDT) -- The U.S. Supreme Court ruled Tuesday that drug companies must disclose adverse event reports if they could affect the company's share price, a decision attorneys say could make it more difficult for companies to defeat securities complaints at the pleading stage.

In a unanimous opinion written by Justice Sonia Sotomayor, the high court ruled that any adverse event reports that alter the “total mix” of information available to investors must be disclosed by drug companies, rejecting a rule proposed by Matrixx Initiatives Inc. that only statistically...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.